News and Events

October 31, 2023

Now Available: Dataset for “Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection”

Authorized researchers may request access to the dataset, which contains more than 3.3 million de-identified data entries and a Data Dictionary.

October 3, 2023

Changes in the body provide clues for the development of Long COVID

A research team that includes RECOVER researchers found changes in the immune systems of people with Long COVID.

September 5, 2023

RECOVER-NEURO enrolls first participant in trial

RECOVER-NEURO will enroll 315 people and test several different treatments for Long COVID patients who have difficulty focusing, thinking clearly, and remembering things.

July 31, 2023

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

Initially, RECOVER will test at least four potential treatments for Long COVID, with test of seven more treatments expected in the coming months.

July 31, 2023

RECOVER-VITAL enrolls first participant in trial

RECOVER-VITAL will enroll 900 people over the next six months and seek to understand whether taking Paxlovid, an antiviral drug, can improve Long COVID symptoms caused by viral persistence.

June 9, 2023

RECOVER Research Q&A: RECOVER “First Look” Adult Cohort Study

Find answers to some of the most frequently asked questions (FAQs) about the first findings from RECOVER's research on Long COVID in adults.

May 23, 2023

Large study provides scientists with deeper insight into long COVID symptoms

RECOVER researchers have identified the 12 symptoms that are most likely to be experienced by adults with Long COVID.

May 11, 2023

Obstructive sleep apnea associated with increased risks for Long COVID

RECOVER researchers examined more than 2.2 million Americans' health data to learn why some people are more likely to develop Long COVID.